drugset / Trial / NCT03794765

Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis

NCT03794765

RandomizedParallel-groupTriple-blindTreatment

Summary

The study is planned as a randomised control trial to study the adjuvant use of antibiotics (ceftriaxone and metronidazole) to achieve a clinical response in hospitalised patients with acute severe ulcerative colitis

Timeline

Start
2019-04-01
Primary completion
2020-03-04
Completion
2020-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftriaxone Other / unclassified 1 g Intravenous
Subject Metronidazole Small molecule 500 mg Intravenous

Indications